Literature DB >> 6991318

Overnight basal insulin requirements in fasting insulin-dependent diabetics.

W L Clarke, M W Haymond, J V Santiago.   

Abstract

Overnight basal insulin requirements to maintain eugycemia were determined in six insulin-requiring diabetic subjects using a feedback-controlled (closed loop) insulin infusion system. Mean hourly insulin infusion rates, required to maintain plasma glucose concentrations at approximately 100 mg/dl, were remarkably stable from 2400 h to 0600 h; however, a twofold to threefold increase in insulin requirements was observed in each subject between 0600 h and 0900 h. This increase in amount of basal insulin required was not associated with increases in plasma glucagon or growth hormone concentrations, but occurred simultaneously with normal diurnal increases in plasma cortisol. These findings suggest that normal diurnal increases in plasma cortisol, independent of the content of the morning meal, contribute to the increased amount of morning insulin required in diabetic subjects. Programs designed for optimal open loop insulin delivery may benefit from modifications designed to coincide with this increase in amount of basal insulin required in the early morning.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991318     DOI: 10.2337/diab.29.1.78

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

2.  Bedtime insulin injections: an alternative regimen.

Authors:  F R Hinde; D I Johnston
Journal:  Arch Dis Child       Date:  1985-04       Impact factor: 3.791

3.  Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1990-01       Impact factor: 10.122

4.  Dawn phenomenon in type 1 (insulin-dependent) diabetic adolescents: influence of nocturnal growth hormone secretion.

Authors:  B Beaufrère; M Beylot; C Metz; A Ruitton; R François; J P Riou; R Mornex
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

Review 5.  Status of pancreatic transplants and mechanical devices for blood glucose control in diabetes.

Authors:  J V Santiago; N H White
Journal:  Ann Biomed Eng       Date:  1980       Impact factor: 3.934

6.  Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.

Authors:  S Del Prato; S Vigili de Kreutzenberg; A Riccio; L Maifreni; E Duner; G Lisato; M Iavicoli; A Tiengo
Journal:  Diabetologia       Date:  1990-11       Impact factor: 10.122

Review 7.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

8.  Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.

Authors:  P De Feo; G Perriello; M M Ventura; F Calcinaro; G Basta; C Lolli; C Cruciani; A Dell'Olio; F Santeusanio; P Brunetti
Journal:  Diabetologia       Date:  1986-08       Impact factor: 10.122

9.  On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, 22-28 September 1985.

Authors:  E F Pfeiffer
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

10.  Dynamic insulin on board: incorporation of circadian insulin sensitivity variation.

Authors:  Chiara Toffanin; Howard Zisser; Francis J Doyle; Eyal Dassau
Journal:  J Diabetes Sci Technol       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.